Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity.

Torrens G, Sánchez-Diener I, Jordana-Lluch E, Barceló IM, Zamorano L, Juan C, Oliver A.

J Infect Dis. 2019 Jul 20. pii: jiz377. doi: 10.1093/infdis/jiz377. [Epub ahead of print]

PMID:
31325363
2.

Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.

Torrens G, Barceló IM, Pérez-Gallego M, Escobar-Salom M, Tur-Gracia S, Munar-Bestard M, González-Nicolau MDM, Cabrera-Venegas YJ, Rigo-Rumbos EN, Cabot G, López-Causapé C, Rojo-Molinero E, Oliver A, Juan C.

Sci Rep. 2019 Mar 5;9(1):3575. doi: 10.1038/s41598-019-40440-w.

3.

In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae.

Moya B, Barcelo IM, Cabot G, Torrens G, Palwe S, Joshi P, Umarkar K, Takalkar S, Periasamy H, Bhagwat S, Patel M, Bou G, Oliver A.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00128-19. doi: 10.1128/AAC.00128-19. Print 2019 May.

PMID:
30782985
4.

Interplay between Peptidoglycan Biology and Virulence in Gram-Negative Pathogens.

Juan C, Torrens G, Barceló IM, Oliver A.

Microbiol Mol Biol Rev. 2018 Sep 12;82(4). pii: e00033-18. doi: 10.1128/MMBR.00033-18. Print 2018 Dec. Review.

PMID:
30209071
5.

Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.

Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01238-17. doi: 10.1128/AAC.01238-17. Print 2017 Nov.

6.

WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.

Moya B, Barcelo IM, Bhagwat S, Patel M, Bou G, Papp-Wallace KM, Bonomo RA, Oliver A.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02529-16. doi: 10.1128/AAC.02529-16. Print 2017 Jun.

Supplemental Content

Loading ...
Support Center